Q4 2024 SI-BONE Inc Earnings Call Transcript
Key Points
- SI-BONE Inc (SIBN) reported a record $49 million in worldwide revenue for Q4 2024, representing over 26% growth.
- U.S. revenue increased by 28% to $46.9 million, driven by strong demand from nearly 1,400 active physicians.
- The company achieved positive adjusted EBITDA in Q4 2024 and expects to maintain this for the full year 2025.
- SI-BONE Inc (SIBN) has successfully launched new products like Granite 9.5 and TNT, which have exceeded adoption expectations.
- The company has a strong liquidity position with $150 million in cash and marketable securities, and is focused on achieving positive free cash flow.
- SI-BONE Inc (SIBN) faces risks related to maintaining favorable reimbursement for its products and procedures.
- There is potential economic weakness that could impact patients' ability and desire to undergo elective procedures.
- The company is involved in an ongoing DOJ investigation, which could pose legal and reputational risks.
- Guidance for 2025 revenue growth is slightly lower at 16% to 17%, compared to previous years' higher growth rates.
- Gross margins are expected to decline slightly in 2025 due to factors like procedure mix and increased depreciation.
Good afternoon, and welcome to SI-BONE's fourth quarter 2024 earnings conference call.
(Operator Instructions) As a reminder, this call is being recorded for replay purposes.
I would now like to turn the call over to Saqib Iqbal, Senior Director of Investor Relations at SI-BONE for a few introductory comments.
Thank you for participating in today's call. Joining me are Laura Francis, Chief Executive Officer; and Anshul Maheshwari, Chief Financial Officer.
Earlier today, SI-BONE released financial results for the quarter ended December 31, 2024. A copy of the press release is available on the company's website.
Before we begin, I'd like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995.
Any statements contained in this call that
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
